scholarly journals Final Results of a Randomized Phase 2 Study Comparing Carboplatin Plus Irinotecan (Ci) Versus Carboplatin Plus Amrubicin (Ca) for Extensive Disease Small-Cell Lung Cancer: Njlcg0901

2014 ◽  
Vol 25 ◽  
pp. iv515
Author(s):  
Y. Tsukita ◽  
N. Morikawa ◽  
S. Sugawara ◽  
M. Maemondo ◽  
T. Harada ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Extensive Disease ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC)

Cancer ◽  
2018 ◽  
Vol 124 (24) ◽  
pp. 4667-4675 ◽  
Author(s):  
Daniel Morgensztern ◽  
Manuel Cobo ◽  
Santiago Ponce Aix ◽  
Pieter E. Postmus ◽  
Conrad R. Lewanski ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals A phase 2 study of irinotecan, cisplatin, and simvastatin for untreated extensive-disease small cell lung cancer

Cancer ◽  
2010 ◽  
Vol 117 (10) ◽  
pp. 2178-2185 ◽  
Author(s):  
Ji-Youn Han ◽  
Kun Young Lim ◽  
Sun Young Yu ◽  
Tak Yun ◽  
Heung Tae Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Extensive Disease ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document